124 related articles for article (PubMed ID: 23554510)
1. Measuring current and future cost of skin cancer in England.
Vallejo-Torres L; Morris S; Kinge JM; Poirier V; Verne J
J Public Health (Oxf); 2014 Mar; 36(1):140-8. PubMed ID: 23554510
[TBL] [Abstract][Full Text] [Related]
2. Modelling the healthcare costs of skin cancer in South Africa.
Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
[TBL] [Abstract][Full Text] [Related]
3. Cost of skin cancer in England.
Morris S; Cox B; Bosanquet N
Eur J Health Econ; 2009 Jul; 10(3):267-73. PubMed ID: 18791757
[TBL] [Abstract][Full Text] [Related]
4. Societal cost of skin cancer in Sweden in 2005.
Tinghög G; Carlsson P; Synnerstad I; Rosdahl I
Acta Derm Venereol; 2008; 88(5):467-73. PubMed ID: 18779884
[TBL] [Abstract][Full Text] [Related]
5. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
6. Cost-of-illness of melanoma in Europe - a modelling approach.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699
[TBL] [Abstract][Full Text] [Related]
7. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
8. Estimating the economic costs of skin cancer in New South Wales, Australia.
Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
[TBL] [Abstract][Full Text] [Related]
9. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
11. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
12. Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure.
Pil L; Hoorens I; Vossaert K; Kruse V; Tromme I; Speybroeck N; Brochez L; Annemans L
Prev Med; 2016 Dec; 93():177-182. PubMed ID: 27713103
[TBL] [Abstract][Full Text] [Related]
13. Cost-of-illness of melanoma in Europe - a systematic review of the published literature.
Krensel M; Schäfer I; Augustin M
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246
[TBL] [Abstract][Full Text] [Related]
14. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
Callum C; Boyle S; Sandford A
Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
[TBL] [Abstract][Full Text] [Related]
15. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
16. The costs of epilepsy misdiagnosis in England and Wales.
Juarez-Garcia A; Stokes T; Shaw B; Camosso-Stefinovic J; Baker R
Seizure; 2006 Dec; 15(8):598-605. PubMed ID: 17011217
[TBL] [Abstract][Full Text] [Related]
17. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
18. An estimate of the cost of treating non-melanoma skin cancer in the state of São Paulo, Brazil.
Souza RJ; Mattedi AP; Corrêa MP; Rezende ML; Ferreira AC
An Bras Dermatol; 2011; 86(4):657-62. PubMed ID: 21987129
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of reduced follow-up in malignant melanoma.
Hengge UR; Wallerand A; Stutzki A; Kockel N
J Dtsch Dermatol Ges; 2007 Oct; 5(10):898-907. PubMed ID: 17910672
[TBL] [Abstract][Full Text] [Related]
20. The future burden of cancer in London compared with England.
Coupland VH; Okello C; Davies EA; Bray F; Møller H
J Public Health (Oxf); 2010 Mar; 32(1):83-9. PubMed ID: 19679689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
